AACR Report: Cancer Progress Stalls as Funding Cuts Threaten Research
The American Association for Cancer Research (AACR) released its 2026 progress report, highlighting significant advances in cancer treatment, including 11 new FDA approvals and a 35% drop in mortality since 1991. However, experts warn that the field is at an 'inflection point' due to threatened federal funding. The report calls for $51.3 billion for the NIH and $8 billion for the National Cancer Institute, criticizing the Trump administration for delaying grants and proposing rules that could politicize scientific merit.